Saudi Pharmaceutical Industries and Medical Appliances Corporation (2070.SR)
SAR 31.65
(-0.32%)
SAR 31.65
(-0.32%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 645 Million SAR | -4.87% |
| 2022 | 678.03 Million SAR | 17.05% |
| 2021 | 579.28 Million SAR | 6.6% |
| 2020 | 543.44 Million SAR | -16.09% |
| 2019 | 647.67 Million SAR | 20.35% |
| 2018 | 538.16 Million SAR | 205.32% |
| 2017 | -510.99 Million SAR | -284.6% |
| 2016 | 276.8 Million SAR | -51.44% |
| 2015 | 570.06 Million SAR | 3.16% |
| 2014 | 552.59 Million SAR | 12.23% |
| 2013 | 492.37 Million SAR | 17.73% |
| 2012 | 418.2 Million SAR | 11.57% |
| 2011 | 374.82 Million SAR | 15.9% |
| 2010 | 323.4 Million SAR | 19.56% |
| 2009 | 270.49 Million SAR | -44.53% |
| 2008 | 487.62 Million SAR | 11.84% |
| 2007 | 436.01 Million SAR | 104.94% |
| 2006 | 212.75 Million SAR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 165 Million SAR | 0.61% |
| 2024 Q2 | 146.8 Million SAR | -11.03% |
| 2023 Q3 | 157.87 Million SAR | 5.98% |
| 2023 Q1 | 174.85 Million SAR | -15.05% |
| 2023 FY | 645 Million SAR | -4.87% |
| 2023 Q2 | 148.97 Million SAR | -14.8% |
| 2023 Q4 | 164 Million SAR | 3.88% |
| 2022 FY | 678.03 Million SAR | 17.05% |
| 2022 Q4 | 205.81 Million SAR | 27.93% |
| 2022 Q3 | 160.88 Million SAR | -5.58% |
| 2022 Q1 | 140.93 Million SAR | -20.06% |
| 2022 Q2 | 170.38 Million SAR | 20.9% |
| 2021 Q4 | 176.3 Million SAR | 36.1% |
| 2021 Q2 | 147.62 Million SAR | 17.34% |
| 2021 FY | 579.28 Million SAR | 6.6% |
| 2021 Q3 | 129.54 Million SAR | -12.24% |
| 2021 Q1 | 125.8 Million SAR | 201.61% |
| 2020 Q1 | -149.63 Million SAR | -164.92% |
| 2020 Q3 | -122.89 Million SAR | -4.16% |
| 2020 FY | 543.44 Million SAR | -16.09% |
| 2020 Q4 | -123.8 Million SAR | -0.75% |
| 2020 Q2 | -117.98 Million SAR | 21.15% |
| 2019 Q2 | -175.12 Million SAR | -233.81% |
| 2019 FY | 647.67 Million SAR | 20.35% |
| 2019 Q3 | 123.51 Million SAR | 170.53% |
| 2019 Q4 | 230.49 Million SAR | 86.62% |
| 2019 Q1 | 130.88 Million SAR | 2.82% |
| 2018 Q3 | -110.97 Million SAR | 3.19% |
| 2018 Q1 | -127.78 Million SAR | 73.43% |
| 2018 FY | 538.16 Million SAR | 205.32% |
| 2018 Q4 | 127.28 Million SAR | 214.7% |
| 2018 Q2 | -114.64 Million SAR | 10.29% |
| 2017 Q2 | -96.67 Million SAR | 39.99% |
| 2017 FY | -510.99 Million SAR | -284.6% |
| 2017 Q3 | 90 Thousand SAR | 100.09% |
| 2017 Q1 | -161.1 Million SAR | -158.2% |
| 2017 Q4 | -480.99 Million SAR | -534513.2% |
| 2016 Q3 | 148.16 Million SAR | -20.81% |
| 2016 Q1 | 161.16 Million SAR | -2.91% |
| 2016 FY | 276.8 Million SAR | -51.44% |
| 2016 Q2 | 187.1 Million SAR | 16.09% |
| 2016 Q4 | 276.8 Million SAR | 86.83% |
| 2015 Q2 | 162.92 Million SAR | 21.12% |
| 2015 Q1 | 134.51 Million SAR | -21.1% |
| 2015 Q3 | 106.62 Million SAR | -34.56% |
| 2015 FY | 570.06 Million SAR | 3.16% |
| 2015 Q4 | 166 Million SAR | 55.69% |
| 2014 Q4 | 170.49 Million SAR | 65.22% |
| 2014 Q3 | 103.18 Million SAR | -31.59% |
| 2014 Q2 | 150.84 Million SAR | 17.78% |
| 2014 Q1 | 128.06 Million SAR | -20.08% |
| 2014 FY | 552.59 Million SAR | 12.23% |
| 2013 Q1 | 113.97 Million SAR | -23.14% |
| 2013 Q3 | 82.1 Million SAR | -40.71% |
| 2013 Q4 | 160.25 Million SAR | 95.18% |
| 2013 FY | 492.37 Million SAR | 17.73% |
| 2013 Q2 | 138.47 Million SAR | 21.5% |
| 2012 Q4 | 148.29 Million SAR | 101.29% |
| 2012 FY | 418.2 Million SAR | 11.57% |
| 2012 Q3 | 73.67 Million SAR | 0.0% |
| 2011 FY | 374.82 Million SAR | 15.9% |
| 2010 FY | 323.4 Million SAR | 19.56% |
| 2009 FY | 270.49 Million SAR | -44.53% |
| 2008 FY | 487.62 Million SAR | 11.84% |
| 2007 FY | 436.01 Million SAR | 104.94% |
| 2006 FY | 212.75 Million SAR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Jamjoom Pharmaceuticals Factory Company | 388.36 Million SAR | -66.082% |